Delaware
|
001-38273
|
94-3290283
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
42307 Osgood Road, Suite I
|
||
Fremont, California
|
94539
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
Class A Common Stock, par value $0.0001 per share |
ACMR
|
The Nasdaq Stock Market LLC
|
Item 2.02. |
Results of Operations and Financial Condition.
|
Item 9.01 |
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit
|
Description
|
|
Press Release of ACM Research, Inc. dated February 26, 2025
|
||
104 | Cover Page Interactive Data File (embedded within the XBRL document) |
ACM RESEARCH, INC.
|
||
By:
|
/s/ Mark McKechnie
|
|
Mark McKechnie
|
||
Chief Financial Officer and Treasurer
|
||
Dated: February 26, 2025
|
Three Months Ended December 31,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
223,471
|
$
|
170,321
|
$
|
223,471
|
$
|
170,321
|
||||||||
Gross margin
|
49.6
|
%
|
46.4
|
%
|
49.8
|
%
|
46.8
|
%
|
||||||||
Income from operations
|
$
|
43,989
|
$
|
23,374
|
$
|
52,773
|
$
|
36,046
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
31,080
|
$
|
17,700
|
$
|
37,740
|
$
|
28,681
|
||||||||
Basic EPS
|
$
|
0.49
|
$
|
0.29
|
$
|
0.60
|
$
|
0.47
|
||||||||
Diluted EPS
|
$
|
0.46
|
$
|
0.26
|
$
|
0.56
|
$
|
0.43
|
Twelve Months Ended December 31,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
782,118
|
$
|
557,723
|
$
|
782,118
|
$
|
557,723
|
||||||||
Gross margin
|
50.1
|
%
|
49.5
|
%
|
50.4
|
%
|
49.8
|
%
|
||||||||
Income from operations
|
$
|
150,998
|
$
|
95,839
|
$
|
200,574
|
$
|
123,177
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
103,627
|
$
|
77,349
|
$
|
152,230
|
$
|
107,424
|
||||||||
Basic EPS
|
$
|
1.67
|
$
|
1.29
|
$
|
2.45
|
$
|
1.79
|
||||||||
Diluted EPS
|
$
|
1.53
|
$
|
1.16
|
$
|
2.26
|
$
|
1.63
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP
Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on
short-term investments.
|
• |
Shipments. Total shipments in 2024 were $973 million, up 63.1%. Total shipments in the fourth quarter of 2024 were $264 million, versus $140 million in the fourth quarter of 2023. Total shipments include deliveries
for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.
|
• |
Thermal and Plasma-Enhanced ALD furnace tools achieved process qualification. ACM announced the achievement of process qualification of its Ultra Fn A Plasma-Enhanced Atomic Layer Deposition (PEALD) and Thermal Atomic Layer Deposition (Thermal ALD) Furnace
tools at two mainland China semiconductor customers.
|
• |
Revenue was $782.1 million, up 40.2%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, along with steady
growth of advanced packaging (excluding ECP), services & spares.
|
• |
Gross margin was 50.1% versus 49.5%.
Non-GAAP gross margin, which excludes stock-based compensation, was 50.4% versus 49.8%. Gross margin exceeded ACM’s updated long-term business model target range of 42% to 48%. ACM expects gross margin to vary from period to period due
to a variety of factors, such as product mix, currency impacts and sales volume.
|
• |
Operating expenses were $240.6 million, an
increase of 33.4%. Operating expenses as a percentage of revenue decreased to 30.8% from 32.3%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $193.4 million, up 25.2%. Non-GAAP operating
expenses as a percentage of revenue were 24.7% compared to 27.7%.
|
• |
Operating income was $151.0 million, up
57.6% compared to $95.8 million. Operating margin increased from 17.2% to 19.3%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $200.6 million, up 62.8% compared to 123.2 million. Non-GAAP
operating margin, which excludes stock-based compensation, was 25.6% compared to 22.1%.
|
• |
Unrealized gain (loss) on short-term investments was $1.0 million, compared to an unrealized gain (loss) of $(2.7) million. Unrealized gain (loss) reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The
value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
|
• |
Income tax expense was $35.0 million,
compared to $19.4 million.
|
• |
Net income attributable to ACM Research, Inc. was $103.6 million, compared to $77.3 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $152.2
million, compared to $107.4 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $1.53, compared to $1.16. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $2.26, compared to $1.63.
|
• |
Cash and cash equivalents, plus restricted
cash and short-term and long-term time deposits were $441.9 million at December 31, 2024, compared to $369.1 million at September 30, 2024.
|
• |
Revenue was $223.5 million, up 31.2%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, along with steady sales growth of advanced packaging (excluding ECP), services & spares.
|
• |
Gross margin was 49.6% versus 46.4%. Non-GAAP gross margin, which excludes stock-based compensation, was 49.8% versus 46.8%. Gross margin was at the upper end of ACM’s updated long-term business model target range of 42% to 48%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
|
• |
Operating expenses were $66.8 million, an increase of 20.0%. Operating expenses as a percentage of revenue decreased to 29.9% from 32.7%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation,
were $58.4 million, up 34.0%. Non-GAAP operating expenses as a percentage of revenue increased to 26.1% from 25.6%.
|
• |
Operating income was $44.0 million, up 88.2% compared to $23.4
million. Operating margin was 19.7% compared to 13.7%. Non-GAAP operating income,
which excludes the effect of stock-based compensation, was $52.8 million, up 46.4% compared to $36.0 million. Non-GAAP operating margin, which excludes stock-based compensation, was 23.6% compared to 21.2%.
|
• |
Unrealized gain on short-term investments was $2.1 million, compared to an unrealized gain of $1.7 million. Unrealized gain reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The value is marked-to-market quarterly and is excluded in the
non-GAAP financial metrics.
|
• |
Income tax expense was $17.3 million, compared to $8.1 million.
|
• |
Net income attributable to ACM Research, Inc. was $31.1 million, compared to $17.7 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $37.7 million, compared to $28.7 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.46, compared to $0.26. Non-GAAP net income per diluted share, which
excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $0.56, compared to $0.43.
|
In the United States:
|
The Blueshirt Group
|
Steven C. Pelayo, CFA
|
|
(360)808-5154
|
|
steven@blueshirtgroup.co
|
|
In China:
|
The Blueshirt Group Asia
|
Gary Dvorchak, CFA
|
|
+86 (138) 1079-1480
|
|
gary@blueshirtgroup.co
|
December 31, 2024
|
December 31, 2023
|
|||||||
(Unaudited)
|
||||||||
(In thousands)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
407,445
|
$
|
182,090
|
||||
Restricted cash
|
3,865
|
1,083
|
||||||
Short-term time deposits
|
17,277
|
80,524
|
||||||
Short-term investment
|
19,373
|
21,312
|
||||||
Accounts receivable, net
|
387,045
|
283,186
|
||||||
Other receivables
|
41,859
|
40,065
|
||||||
Inventories, net
|
597,984
|
545,395
|
||||||
Advances to related party
|
1,024
|
2,432
|
||||||
Prepaid expenses
|
7,507
|
20,023
|
||||||
Total current assets
|
1,483,379
|
1,176,110
|
||||||
Property, plant and equipment, net
|
269,272
|
201,848
|
||||||
Operating lease right-of-use assets, net
|
14,038
|
15,393
|
||||||
Intangible assets, net
|
3,461
|
2,538
|
||||||
Long-term time deposits
|
13,275
|
40,818
|
||||||
Deferred tax assets
|
14,781
|
20,271
|
||||||
Long-term investments
|
37,063
|
27,880
|
||||||
Other long-term assets
|
20,452
|
6,050
|
||||||
Total assets
|
$
|
1,855,721
|
$
|
1,490,908
|
||||
Liabilities and Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
$
|
32,814
|
$
|
31,335
|
||||
Current portion of long-term borrowings
|
44,472
|
6,783
|
||||||
Related party accounts payable
|
16,133
|
11,407
|
||||||
Accounts payable
|
139,294
|
141,814
|
||||||
Advances from customers
|
243,949
|
181,368
|
||||||
Deferred revenue
|
8,537
|
3,687
|
||||||
Income taxes payable
|
12,779
|
6,401
|
||||||
FIN-48 payable
|
19,466
|
12,149
|
||||||
Other payables and accrued expenses
|
121,657
|
102,951
|
||||||
Current portion of operating lease liability
|
2,132
|
2,764
|
||||||
Total current liabilities
|
641,233
|
500,659
|
||||||
Long-term borrowings
|
105,525
|
53,952
|
||||||
Long-term operating lease liability
|
3,840
|
4,262
|
||||||
Other long-term liabilities
|
9,217
|
5,873
|
||||||
Total liabilities
|
759,815
|
564,746
|
||||||
Commitments and contingencies
|
||||||||
Equity:
|
||||||||
Stockholders’ equity:
|
||||||||
Class A Common stock
|
6
|
6
|
||||||
Class B Common stock
|
1
|
1
|
||||||
Additional paid-in capital
|
677,476
|
629,845
|
||||||
Retained earnings
|
260,000
|
156,827
|
||||||
Statutory surplus reserve
|
30,514
|
30,060
|
||||||
Accumulated other comprehensive loss
|
(63,372
|
)
|
(49,349
|
)
|
||||
Total ACM Research, Inc. stockholders’ equity
|
904,625
|
767,390
|
||||||
Non-controlling interests
|
191,281
|
158,772
|
||||||
Total equity
|
1,095,906
|
926,162
|
||||||
Total liabilities and equity
|
$
|
1,855,721
|
$
|
1,490,908
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
( In thousands, except share and per share data)
|
||||||||||||||||
Revenue
|
$
|
223,471
|
$
|
170,321
|
$
|
782,118
|
$
|
557,723
|
||||||||
Cost of revenue
|
112,656
|
91,245
|
390,564
|
281,508
|
||||||||||||
Gross profit
|
110,815
|
79,076
|
391,554
|
276,215
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
18,380
|
9,440
|
65,447
|
47,019
|
||||||||||||
Research and development
|
27,750
|
32,465
|
105,473
|
92,709
|
||||||||||||
General and administrative
|
20,696
|
13,797
|
69,636
|
40,648
|
||||||||||||
Total operating expenses
|
66,826
|
55,702
|
240,556
|
180,376
|
||||||||||||
Income from operations
|
43,989
|
23,374
|
150,998
|
95,839
|
||||||||||||
Interest income
|
2,813
|
2,071
|
9,935
|
8,354
|
||||||||||||
Interest expense
|
(1,228
|
)
|
(697
|
)
|
(4,151
|
)
|
(2,681
|
)
|
||||||||
Realized gain from sale of short-term investments
|
1,344
|
478
|
1,788
|
9,047
|
||||||||||||
Unrealized gain (loss) on short-term investments
|
2,124
|
1,691
|
973
|
(2,737
|
)
|
|||||||||||
Other income (expense), net
|
7,061
|
(1,714
|
)
|
6,334
|
(1,558
|
)
|
||||||||||
Income from equity method investments
|
322
|
6,224
|
423
|
9,952
|
||||||||||||
Income before income taxes
|
56,425
|
31,427
|
166,300
|
116,216
|
||||||||||||
Income tax expense
|
(17,319
|
)
|
(8,129
|
)
|
(35,031
|
)
|
(19,364
|
)
|
||||||||
Net income
|
39,106
|
23,298
|
131,269
|
96,852
|
||||||||||||
Less: Net income attributable to non-controlling interests
|
8,026
|
5,598
|
27,642
|
19,503
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
31,080
|
$
|
17,700
|
$
|
103,627
|
$
|
77,349
|
||||||||
Comprehensive income (loss):
|
||||||||||||||||
Net income
|
39,106
|
23,298
|
131,269
|
96,852
|
||||||||||||
Foreign currency translation adjustment, net of tax
|
(26,104
|
)
|
11,214
|
(15,728
|
)
|
(10,617
|
)
|
|||||||||
Unrealized gain on available-for-sale investments, net of tax
|
428
|
-
|
428
|
-
|
|
|||||||||||
Comprehensive Income
|
13,430
|
34,512
|
115,969
|
86,235
|
||||||||||||
Less: Comprehensive income attributable to non-controlling interests
|
$
|
4,909
|
$
|
5,807
|
$
|
26,365
|
$
|
17,689
|
||||||||
Comprehensive income (loss) attributable to ACM Research Inc.
|
$
|
8,521
|
$
|
28,705
|
$
|
89,604
|
$
|
68,546
|
||||||||
Basic
|
$
|
0.49
|
$
|
0.29
|
$
|
1.67
|
$
|
1.29
|
||||||||
Diluted
|
$
|
0.46
|
$
|
0.26
|
$
|
1.53
|
$
|
1.16
|
||||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
62,794,259
|
60,792,349
|
62,212,569
|
60,164,670
|
||||||||||||
Diluted
|
66,518,704
|
65,911,901
|
66,237,424
|
64,870,543
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
($ in thousand)
|
||||||||||||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
$
|
155,211
|
$
|
122,292
|
$
|
578,887
|
$
|
403,851
|
||||||||
ECP (front-end and packaging), furnace and other technologies
|
51,695
|
32,133
|
151,057
|
103,356
|
||||||||||||
Advanced packaging (excluding ECP), services & spares
|
16,565
|
15,896
|
52,174
|
50,516
|
||||||||||||
Total Revenue By Product Category
|
$
|
223,471
|
$
|
170,321
|
$
|
782,118
|
$
|
557,723
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
Mainland China
|
$
|
223,110
|
$
|
165,441
|
$
|
775,752
|
$
|
540,969
|
||||||||
Other Regions
|
361
|
4,880
|
6,366
|
16,754
|
||||||||||||
Total Revenue By Region
|
$
|
223,471
|
$
|
170,321
|
$
|
782,118
|
$
|
557,723
|
Three Months Ended December 31,
|
||||||||||||||||||||||||||||||||
2024
|
2023
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
(Non-
GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
(Non-
GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
223,471
|
$
|
-
|
$
|
-
|
$
|
223,471
|
$
|
170,321
|
$
|
-
|
$
|
-
|
$
|
170,321
|
||||||||||||||||
Cost of revenue
|
(112,656
|
)
|
(365
|
)
|
-
|
(112,291
|
)
|
(91,245
|
)
|
(568
|
)
|
-
|
(90,677
|
)
|
||||||||||||||||||
Gross profit
|
110,815
|
(365
|
)
|
-
|
111,180
|
79,076
|
(568
|
)
|
-
|
79,644
|
||||||||||||||||||||||
Gross margin
|
49.6
|
%
|
0.2
|
%
|
-
|
49.8
|
%
|
46.4
|
%
|
0.3
|
%
|
-
|
46.8
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(18,380
|
)
|
(1,907
|
)
|
-
|
(16,473
|
)
|
(9,440
|
)
|
(2,279
|
)
|
-
|
(7,161
|
)
|
||||||||||||||||||
Research and development
|
(27,750
|
)
|
(2,030
|
)
|
-
|
(25,720
|
)
|
(32,465
|
)
|
(3,628
|
)
|
-
|
(28,837
|
)
|
||||||||||||||||||
General and administrative
|
(20,696
|
)
|
(4,482
|
)
|
-
|
(16,214
|
)
|
(13,797
|
)
|
(6,197
|
)
|
-
|
(7,600
|
)
|
||||||||||||||||||
Total operating expenses
|
(66,826
|
)
|
(8,419
|
)
|
-
|
(58,407
|
)
|
(55,702
|
)
|
(12,104
|
)
|
-
|
(43,598
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
43,989
|
$
|
(8,784
|
)
|
$
|
-
|
$
|
52,773
|
$
|
23,374
|
$
|
(12,672
|
)
|
$
|
-
|
$
|
36,046
|
||||||||||||||
Unrealized gain on short-term investments
|
2,124
|
-
|
2,124
|
-
|
1,691
|
-
|
1,691
|
-
|
||||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
31,080
|
$
|
(8,784
|
)
|
$
|
2,124
|
$
|
37,740
|
$
|
17,700
|
$
|
(12,672
|
)
|
$
|
1,691
|
$
|
28,681
|
||||||||||||||
Basic EPS
|
$
|
0.49
|
$
|
0.60
|
$
|
0.29
|
$
|
0.47
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.46
|
$
|
0.56
|
$
|
0.26
|
$
|
0.43
|
Year Ended December 31,
|
||||||||||||||||||||||||||||||||
2024
|
2023
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
(Non-
GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
(Non-
GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
782,118
|
$
|
-
|
$
|
-
|
$
|
782,118
|
$
|
557,723
|
$
|
-
|
$
|
-
|
$
|
557,723
|
||||||||||||||||
Cost of revenue
|
(390,564
|
)
|
(2,385
|
)
|
-
|
(388,179
|
)
|
(281,508
|
)
|
(1,406
|
)
|
-
|
(280,102
|
)
|
||||||||||||||||||
Gross profit
|
391,554
|
(2,385
|
)
|
-
|
393,939
|
276,215
|
(1,406
|
)
|
-
|
277,621
|
||||||||||||||||||||||
Gross margin
|
50.1
|
%
|
0.3
|
%
|
-
|
50.4
|
%
|
49.5
|
%
|
0.3
|
%
|
-
|
49.8
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(65,447
|
)
|
(10,552
|
)
|
-
|
(54,895
|
)
|
(47,019
|
)
|
(5,684
|
)
|
-
|
(41,335
|
)
|
||||||||||||||||||
Research and development
|
(105,473
|
)
|
(14,112
|
)
|
-
|
(91,361
|
)
|
(92,709
|
)
|
(8,459
|
)
|
-
|
(84,250
|
)
|
||||||||||||||||||
General and administrative
|
(69,636
|
)
|
(22,527
|
)
|
-
|
(47,109
|
)
|
(40,648
|
)
|
(11,789
|
)
|
-
|
(28,859
|
)
|
||||||||||||||||||
Total operating expenses
|
(240,556
|
)
|
(47,191
|
)
|
-
|
(193,365
|
)
|
(180,376
|
)
|
(25,932
|
)
|
-
|
(154,444
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
150,998
|
$
|
(49,576
|
)
|
$
|
-
|
$
|
200,574
|
$
|
95,839
|
$
|
(27,338
|
)
|
$
|
-
|
$
|
123,177
|
||||||||||||||
Unrealized gain (loss) on short-term investments
|
973
|
-
|
973
|
-
|
(2,737
|
)
|
-
|
(2,737
|
)
|
-
|
||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
103,627
|
$
|
(49,576
|
)
|
$
|
973
|
$
|
152,230
|
$
|
77,349
|
$
|
(27,338
|
)
|
$
|
(2,737
|
)
|
$
|
107,424
|
|||||||||||||
Basic EPS
|
$
|
1.67
|
$
|
2.45
|
$
|
1.29
|
$
|
1.79
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
1.53
|
$
|
2.26
|
$
|
1.16
|
$
|
1.63
|